Answer
Zynlonta (loncastuximab tesirine) must not be mixed with or administered as an infusion with other medicinal products except those mentioned in section 6.6 of its SmPC.
Sources for this answer
- Zynlonta, 10mg, powder for concentrate for solution for infusionSwedish Orphan Biovitrum Ltd · emc · SmPC §6.2 Incompatibilities · Version 8Document updated
Sources checked